Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.41 USD
Change Today +0.06 / 1.79%
Volume 66.1K
EDAP On Other Exchanges
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

edap tms sa -adr (EDAP) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/8/14 - $6.05
52 Week Low
10/10/14 - $1.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EDAP TMS SA -ADR (EDAP)

edap tms sa -adr (EDAP) Related Businessweek News

No Related Businessweek News Found

edap tms sa -adr (EDAP) Details

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It also offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. In addition, this division leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, markets, manufactures, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It also offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of ESWL technology. In addition, this division is engages in the leasing of lithotripters; sale of disposables and spare parts; and provision of maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

161 Employees
Last Reported Date: 04/2/15
Founded in 1979

edap tms sa -adr (EDAP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

edap tms sa -adr (EDAP) Key Developments

EDAP TMS SA Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

EDAP TMS SA reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total net sales of $6,217,000 against $7,762,000 a year ago. Total revenues were $6,217,000 against $7,765,000 a year ago. Operating loss was $622,000 against operating income of $558,000 a year ago. Loss before taxes and minority interest was $2,410,000 against income before taxes and minority interest of $870,000 a year ago. Basic and diluted net loss per share was $0.10 against basic and diluted net income per share of $0.04 a year ago.

EDAP TMS SA to Report Q1, 2015 Results on May 13, 2015

EDAP TMS SA announced that they will report Q1, 2015 results at 8:30 AM, US Eastern Standard Time on May 13, 2015

EDAP TMS SA, Q1 2015 Earnings Call, May 13, 2015

EDAP TMS SA, Q1 2015 Earnings Call, May 13, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EDAP:US $3.41 USD +0.06

EDAP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elbit Imaging Ltd 686.60 -9.30
Integra LifeSciences Holdings Corp $67.58 USD +0.41
Johnson & Johnson $100.04 USD -0.10
Stryker Corp $96.12 USD -0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation EDAP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.1x
Price/Book 5.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDAP TMS SA -ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at